Canada’s health regulator has authorized the COVID-19 vaccine from Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX).
Pfizer submitted documentation related to the BNT162b2 vaccine to Canadian regulators on Oct. 9, 2020.
“Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place,” Health Canada explained in a statement. The agency also stressed it would carefully monitor the safety of the vaccine and “will not hesitate to take action if any safety concerns are identified.”
Get the full story from our sister site, Pharmaceutical Processing World.